Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CannaPharmaRx Inc CPMD

Healthcare Cannabis
CannaPharmaRX Inc. is a Canada-based cannabis company focused on producing customizable medical cannabis and craft products. The Company operates from its facility in Cremona, AB, Canada, and is able to produce over 6,000 kgs per year. The Company is focused on evaluation, negotiation, acquisition, and development cannabis cultivation projects in Canada. The Company's products include unique... see more

Recent & Breaking News (OTCPK:CPMD)

CannapharmaRx to Complete Additional Shipment in November

Accesswire November 5, 2024

CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product

Accesswire August 15, 2024

Q1 2024 Financial Results

Accesswire June 28, 2024

CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call

Accesswire May 20, 2024

CannaPharmaRx to Host Investor Conference Call

Accesswire May 20, 2024

CannapharmaRx Pays Off Convertible Notes

Accesswire April 2, 2024

CannapharmaRx Receives First Purchase Order and Begins Shipment of Product

Accesswire March 14, 2024

CannaPharmaRx Completes First Harvests

Accesswire March 12, 2024

CannaPharmaRx to Hold Investor Conference Call

Accesswire March 7, 2024

CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas

Accesswire March 5, 2024

CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration

Accesswire February 23, 2024

CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek

Accesswire February 16, 2024

CannaPharmaRx CEO Provides Annual Update Message

Accesswire February 15, 2024

CannaPharmaRx Expands Board of Directors

Accesswire August 25, 2023

CannaPharmaRx Appoints Dean Medwid as New CEO

Accesswire June 23, 2023

CannaPharmaRx Signs Agreement with Nasha Genetics

Accesswire April 19, 2023

CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis

Accesswire March 30, 2023

CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website

Accesswire March 21, 2023

CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company

Accesswire February 21, 2023

CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock

Accesswire February 1, 2023